Day: August 12, 2024

– Recent Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrated Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints – – Strengthened Balance Sheet with $374 Million Public Offering Extending Projected Cash Runway At Least Into the Second Half of 2026 – WALTHAM, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the second quarter of 2024 and recent business highlights. “The second quarter of 2024 was an exciting one for our clinical programs and pipeline. We reported new clinical data from our ACHIEVE and DELIVER...

Ongoing improvement to ASP and profitability of foundational PAC business 52% of Red River’s GAC nameplate capacity now contracted nearly six months ahead of first production Red River expansion remains on target for first GAC deliveries in Q1 2025 GREENWOOD VILLAGE, Colo., Aug. 12, 2024 (GLOBE NEWSWIRE) — Arq, Inc. (NASDAQ: ARQ) (the “Company” or “Arq”), a producer of activated carbon and other environmentally efficient carbon products for use in purification and sustainable materials, today announced its financial and operating results for the quarter ended June 30, 2024. Financial HighlightsGenerated revenue of $25.4 million in Q2 2024, up 24% over the prior year period, driven by enhanced contract terms including higher average selling prices (“ASP”) and positive changes in product mix Increased ASP...

CALGARY, Alberta, Aug. 12, 2024 (GLOBE NEWSWIRE) — GINSMS Inc. (TSXV: GOK) (the “Corporation”) has announced its financial results for the second quarter ended June 30, 2024. The complete financial results for GINSMS are available at www.sedar.com. Highlights include:Revenue of $815,190 for the three-month period ended June 30, 2024 as compared of $840,372 for the three-month period ended June 30, 2023. Gross Profit of $428,725 for the three-month period ended June 30, 2024 as compared to gross profit of $306,419 for the three-month period ended June 30, 2023. Operating expenses and finance costs of $232,918 for the three-month period ended June 30, 2024 increased from $211,157 for the three-month period ended June 30, 2023 . Net profit of $203,164 for three-month period ended June 30, 2024 as compared to a net profit of $102,437...

Net Income was $21.5 million, an increase of 236% from a year earlier, Gross Margin was 31.8%, an increase of 9.7% from a year earlier, EPS were $0.94, an increase of $0.66 from a year earlier, Debt decreased $5.0 million,  Shareholder Equity increased to $24.8 million. WOOD DALE, Ill., Aug. 12, 2024 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (the “Company” or “PSI”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announces second quarter 2024 financial results. Second Quarter 2024 Results Today, Power Solutions International, Inc., reported record profit for the three months ended June 30, 2024, with net income of $21.5 million and diluted earnings per share of $0.94, compared to net income of $6.4 million and diluted earnings per share of $0.28...

Orlando, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) — CNL Strategic Capital, LLC (CNL Strategic Capital or the Company) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the six months ended June 30, 2024. Highlights:As of June 30, 2024, CNL Strategic Capital’s portfolio consisted of equity and debt investments in 15 portfolio companies and had approximately $1.1 billion in total assets, compared with approximately $1.0 billion as of Dec. 31, 2023. For the six months ended June 30, 2024, the Company recognized a net change in unrealized appreciation on investments of approximately $35.2 million and had total investment income of approximately $32.1...

Quarterly Bookings Improve as VirTra Advances Product Launches and Expands Focus on Federal and Defense Markets CHANDLER, Ariz., Aug. 12, 2024 (GLOBE NEWSWIRE) — VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators, firearms training simulators for the law enforcement and military markets, reported results for the second quarter ended June 30, 2024. The financial statements are available on VirTra’s website and here. Second Quarter 2024 and Recent Operational Highlights:Bookings increased by $3 million quarter-over-quarter, doubling since Q1, highlighting improved market conditions and a strengthened sales approach. Gross margins improved to 91%, marking a significant increase from 83% in Q1. Maintained robust working capital at $34.8 million, positioning the...

NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its second quarter 2024 financial results and provided a business update. “Our work in hypertension and coronary artery disease aligns with a renaissance occurring in cardiac pacing and balloon angioplasty, applying new innovations to enhance these foundational device-based interventions and create more potent therapeutic solutions. At our inaugural R&D day in June, we were excited to share our insights into this renaissance and the potential role we believe our lead programs – AVIM therapy and Virtue SAB – will play in improving outcomes for patients....

HAMILTON, BERMUDA, August 12, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended June 30, 2024. The full report is available here and in the below attachment. About DHT Holdings, Inc.DHT is an independent crude oil tanker company. Our fleet trades internationally and consists of crude oil tankers in the VLCC segment. We operate through our integrated management companies in Monaco, Norway, Singapore, and India. You may recognize us by our renowned business approach as an experienced organization with focus on first rate operations and customer service; our quality ships; our prudent capital structure that promotes staying power through the business cycles; our combination of market exposure and fixed income contracts for our fleet; our counter cyclical philosophy with respect...